Clinical trial Recruiting at 1 site Observational Ages 18 and up

Understanding lung endothelial barrier integrity in sepsis

Official title: Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis

Run by Mater Dei Hospital, Malta · NCT06287684 · Data updated 2026-11-12

This study is trying to find out how the lungs are affected in people with sepsis to see if certain blood markers can help predict their recovery and guide better treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment460 (estimated)
SponsorMater Dei Hospital, Malta
Academic / other
Locations1 site (Msida)
StatusRecruiting
StartedSeptember 13, 2023
Main results expectedDecember 30, 2028
Study endsDecember 30, 2028
Registry record updatedJuly 16, 2025
Trial IDNCT06287684 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with acute respiratory tract infections due to pneumonia.

Probably not a fit

Patients who are pregnant, prisoners, or have conditions like aspiration pneumonitis or ventilator-associated pneumonia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the dynamics of lung endothelial barrier integrity in patients with sepsis, septic shock, and pneumonia. It aims to classify sepsis patients into molecular endotypes to better understand their prognosis and response to treatment. By utilizing blood transcriptomics and bronchoalveolar lavage protein profiling, the study seeks to identify specific biomarkers associated with poor outcomes in sepsis. The findings could help tailor therapeutic interventions based on individual patient profiles.

Why it matters

Potential benefit: If successful, this study could lead to more personalized treatment strategies for sepsis patients, improving their outcomes.

How similar studies have gone: While the approach of classifying sepsis patients into molecular endotypes is gaining traction, this specific study's methodology is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Age ≥ 18 years
* Consent card signed

Exclusion criteria:

* Consent card not signed
* Pregnancy
* Prisoners
* Elective cardiac surgery patients with an uncomplicated stay.

Where it's running

  • Mater Dei hospital, Intensive Therapy Unit
    Msida, Malta
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.